Print(PDF/176KB) Mar. 05, 2024 Corporate
Sumitomo Pharma Announces Organizational Realignment and Changes in Executive Officers and Other Key Positions
Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura) today announced the following organizational realignment and changes in Executive Officers and other key positions, effective April 1, 2024.
I. Organizational Realignment (effective April 1, 2024)
Sales & Marketing (Division)
CNS Sales Department is dissolved and Psychiatry Groups belonging to CNS
Sales Department are transferred to Branches.
II. Changes in Executive Officers
- 1.New Executive Officer (effective April 1, 2024)
- Yutaka Wakemi (currently Vice President, Head of Global Corporate Strategy)
- 2.Departing Executive Officers (effective March 31, 2024)
- Takuya Taguchi (currently Managing Executive Officer)
Myrtle Potter (currently Executive Officer)
Armin Szegedi (currently Executive Officer) - 3.Changes in the Positions Assumed by Executive Officers (effective April 1, 2024)
Position as of April 1, 2024 | Current position | Name |
---|---|---|
Member, Board of Directors, Managing Executive Officer Business Development & Management Vice President, Head of Business Development & Management |
Member, Board of Directors, Managing Executive Officer Business Development & Management |
Shigeyuki Nishinaka |
Executive Officer
Drug Development Division Senior Vice President, Head of Drug Development Division Chief Development Officer, Sumitomo Pharma America, Inc. |
Executive Officer Drug Development Division Senior Vice President, Head of Drug Development Division CNS Strategic Alliance, Sumitomo Pharma America, Inc. |
Yumi Sato |
Executive Officer President and CEO, Sumitomo Pharma America, Inc. |
Executive Officer Chief Strategy Officer, Sumitomo Pharma America, Inc. |
Tsutomu Nakagawa |
Executive Officer Vice President, Head of Global Corporate Strategy |
Vice President, Head of Global Corporate Strategy | Yutaka Wakemi |
III. Changes in Personnel (effective April 1, 2024)
Corporate Departments
Position as of April 1, 2024 | Current position | Name |
---|---|---|
Senior Business Development Officer | Senior Alliance Officer | Hiroko Yuasa |
Vice President, Sumitomo Pharma America, Inc. | Vice President, Head of Development Regulatory Affairs | Kenichi Otani |
Vice President, Sumitomo Pharma America, Inc. | Vice President, Head of Clinical Operation | Taiji Ono |
Corporate Regulatory Compliance & Quality Assurance (Division)
Position as of April 1, 2024 | Current position | Name |
---|---|---|
Vice President, Head of Regulatory Compliance & Quality Assurance Management | Senior Director, Research & Pharmacovigilance QA Group, Regulatory Compliance & Quality Assurance Management |
Kaori Kato |
Vice President, Head of Pharmacovigilance | Senior Director, Medical Governance Group, Medical Science | Ikuko Harada |
Drug Development (Division)
Position as of April 1, 2024 | Current position | Name |
---|---|---|
Vice President, Head of Development Regulatory Affairs Senior Director, Development RA Group, Development Regulatory Affairs |
Senior Director, Development RA Group, Development Regulatory Affairs | San Go |
Vice President, Head of Clinical Operation | Clinical Development Officer, Regenerative & Cellular Medicine Office | Hideaki Takahashi |
Sales & Marketing (Division)
Position as of April 1, 2024 | Current position | Name |
---|---|---|
Sales & Marketing Division Senior Vice President, Head of Sales & Marketing Division Deputy Head of Japan Business Unit |
Senior Vice President, Deputy Head of Sales & Marketing Division Vice President, Head of Tokyo Branch | Koji Yamazaki |
Distribution Management | Vice President, Head of Distribution Management | Toshinobu Shiina |
Vice President, Head of Sales & Marketing Management | Vice President, Head of Sales & Marketing Management Vice President, Head of MarTech Strategy Office | Yasutoshi Araki |
Vice President, Head of MarTech Strategy Office | Senior Director, Analysis Group, Sales & Marketing Management | Kota Nishiyama |
Vice President, Head of Distribution Management | Vice President, Head of Kyushu Branch | Manabu Tatsukawa |
Vice President, Head of Tohoku Branch Senior Director, Wholesaler Service Group, Tohoku Branch | Senior Director, Miyagi Group, Tohoku Branch | Hirofumi Sugii |
Vice President, Head of Kita-Kanto-Koshinetsu Branch | Senior Director, CNS Product Group Ⅱ, CNS Product Marketing | Hiroshi Ogawa |
Vice President, Head of Tokyo Branch | Vice President, Head of Tohoku Branch | Katsuhiko Nishida |
Vice President, Head of Tokai Branch Senior Director, Wholesaler Service Group, Tokai Branch | Vice President, Head of Kita-Kanto-Koshinetsu Branch | Satsuki Otani |
Vice President, Head of Kyushu Branch | Vice President, Head of Tokai Branch | Hiroshi Takaoka |
Manufacturing (Division)
Position as of April 1, 2024 | Current position | Name |
---|---|---|
Vice President, Head of Manufacturing Technology Senior Director, Packaging Technology Group, Manufacturing Technology |
Vice President, Head of Quality Assurance, Suzuka Plant | Takahiro Jikihara |
Vice President, Head of Quality Assurance, Suzuka Plant | Senior Director, Quality Assurance Group, Quality Assurance, Suzuka Plant | Tadashi Nobata |
Vice President, Head of Manufacturing Department Ⅰ, Suzuka Plant | Senior Director, Narcotics Manufacturing Section, Manufacturing Department Ⅱ, Suzuka Plant | Satoshi Nakao |
Inquiries from the Press